北京奥司他韦近7天销量暴涨237%

Core Insights - The flu activity in China has rapidly increased since November, with Beijing entering a high incidence period for respiratory infectious diseases [1] - Sales of antiviral medications have surged, with Oseltamivir experiencing a 237% increase in sales over the past week, and Baloxavir Marboxil (Xofluza) seeing an increase of 180% [1] - Despite the surge in demand for flu medications, inventory levels for popular antiviral drugs remain sufficient, with availability for both online and offline purchases [1]